These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17434318)

  • 1. Human topoisomerase I C-terminal domain fragment containing the active site tyrosine is a molten globule: implication for the formation of competent productive complex.
    Punchihewa C; Dai J; Carver M; Yang D
    J Struct Biol; 2007 Jul; 159(1):111-21. PubMed ID: 17434318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of human topoisomerase I by fragment complementation.
    Stewart L; Ireton GC; Champoux JJ
    J Mol Biol; 1997 Jun; 269(3):355-72. PubMed ID: 9199405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The domain organization and properties of individual domains of DNA topoisomerase V, a type 1B topoisomerase with DNA repair activities.
    Belova GI; Prasad R; Nazimov IV; Wilson SH; Slesarev AI
    J Biol Chem; 2002 Feb; 277(7):4959-65. PubMed ID: 11733530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raman and CD spectroscopy of recombinant 68-kDa DNA human topoisomerase I and its complex with suicide DNA-substrate.
    Fleury F; Ianoul A; Kryukov E; Sukhanova A; Kudelina I; Wynne-Jones A; Bronstein IB; Maizieres M; Berjot M; Dodson GG; Wilkinson AJ; Holden JA; Feofanov AV; Alix AJ; Jardillier JC; Nabiev I
    Biochemistry; 1998 Oct; 37(41):14630-42. PubMed ID: 9772192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and biophysical analyses of recombinant forms of human topoisomerase I.
    Stewart L; Ireton GC; Parker LH; Madden KR; Champoux JJ
    J Biol Chem; 1996 Mar; 271(13):7593-601. PubMed ID: 8631793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal domain but not the tyrosine 723 of human DNA topoisomerase I active site contributes to kinase activity.
    Rossi F; Labourier E; Gallouzi IE; Derancourt J; Allemand E; Divita G; Tazi J
    Nucleic Acids Res; 1998 Jun; 26(12):2963-70. PubMed ID: 9611242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures.
    Redinbo MR; Stewart L; Champoux JJ; Hol WG
    J Mol Biol; 1999 Sep; 292(3):685-96. PubMed ID: 10497031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of one of the apurinic/apyrimidinic lyase active sites of topoisomerase V by structural and functional studies.
    Rajan R; Prasad R; Taneja B; Wilson SH; Mondragón A
    Nucleic Acids Res; 2013 Jan; 41(1):657-66. PubMed ID: 23125368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status.
    Mao Y; Mehl IR; Muller MT
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1235-40. PubMed ID: 11805286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3',5'-monophosphate response element-binding protein and related transcription factors.
    Kroll DJ; Sullivan DM; Gutierrez-Hartmann A; Hoeffler JP
    Mol Endocrinol; 1993 Mar; 7(3):305-18. PubMed ID: 8387155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The domain organization of human topoisomerase I.
    Stewart L; Ireton GC; Champoux JJ
    J Biol Chem; 1996 Mar; 271(13):7602-8. PubMed ID: 8631794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of topoisomerase I in its complex with SRSF1.
    Ishikawa T; Krzysko KA; Kowalska-Loth B; Skrajna AM; Czubaty A; Girstun A; Cieplak MK; Lesyng B; Staron K
    Biochemistry; 2012 Feb; 51(8):1803-16. PubMed ID: 22320324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal domains of Escherichia coli topoisomerase I belong to the zinc-ribbon superfamily.
    Grishin NV
    J Mol Biol; 2000 Jun; 299(5):1165-77. PubMed ID: 10873443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dimerization domain of HNF-1alpha: structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus.
    Narayana N; Hua Q; Weiss MA
    J Mol Biol; 2001 Jul; 310(3):635-58. PubMed ID: 11439029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equilibrium phi-analysis of a molten globule: the 1-149 apoflavodoxin fragment.
    López-Llano J; Campos LA; Bueno M; Sancho J
    J Mol Biol; 2006 Feb; 356(2):354-66. PubMed ID: 16364364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domains of human topoisomerase I and associated functions.
    Champoux JJ
    Prog Nucleic Acid Res Mol Biol; 1998; 60():111-32. PubMed ID: 9594573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calf-thymus topoisomerase I equilibrates metastable secondary structure subsequent to relaxation of superhelical stress.
    Brewood GP; Delrow JJ; Schurr JM
    Biochemistry; 2010 Apr; 49(16):3367-80. PubMed ID: 20178373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methanopyrus kandleri topoisomerase V contains three distinct AP lyase active sites in addition to the topoisomerase active site.
    Rajan R; Osterman A; Mondragón A
    Nucleic Acids Res; 2016 Apr; 44(7):3464-74. PubMed ID: 26908655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indispensable, functionally complementing N and C-terminal domains constitute site-specific topoisomerase I.
    Jain P; Nagaraja V
    J Mol Biol; 2006 Apr; 357(5):1409-21. PubMed ID: 16490213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary and tertiary structural changes in gamma delta resolvase: comparison of the wild-type enzyme, the I110R mutant, and the C-terminal DNA binding domain in solution.
    Pan B; Deng Z; Liu D; Ghosh S; Mullen GP
    Protein Sci; 1997 Jun; 6(6):1237-47. PubMed ID: 9194184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.